Signatera Assessment in Early-Stage Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam ElNaggar, MD
Natera, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Hospital
Birmingham, Alabama, United States
Michael Toboni, MD - University of California, San Diego
La Jolla, California, United States
Ramez Eskander, MD - University of California, Los Angeles
Los Angeles, California, United States
Dana Chase, MD - University of Miami
Miami, Florida, United States
Abdulrahman Sinno, MD - University of Chicago
Chicago, Illinois, United States
Katherine Kurnit, MD - University of Minnesota
Minneapolis, Minnesota, United States
Melissa Geller, MD - New York University
New York, New York, United States
Bhavana Pothuri, MD - Atrium Health Levine Cancer
Charlotte, North Carolina, United States
Allison Puechl, MD - Duke University
Durham, North Carolina, United States
Angeles Secord, MD - Cleveland Clinic
Cleveland, Ohio, United States
Kevin Elias, MD - Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Floor Backes, MD - Allegheny Health
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2026
- Primary completion
- 31 Oct 2034
- Completion
- 31 Oct 2034
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 1,010
- Registry id
- NCT07339384
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.